Phibro Animal Health Corporation
PAHC
$23.64
$0.331.42%
| Weiss Ratings | PAHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Reward Grade | C+ | |||
| Rating Factors | PAHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Fair | |||
| Growth Index | Fair | |||
| Efficiency Index | Good | |||
| Solvency Index | Good | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | PAHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.92 | |||
| Price History | PAHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 6.95% | |||
| 30-Day Total Return | 7.94% | |||
| 60-Day Total Return | 1.38% | |||
| 90-Day Total Return | 0.91% | |||
| Year to Date Total Return | 14.11% | |||
| 1-Year Total Return | 85.35% | |||
| 2-Year Total Return | 51.74% | |||
| 3-Year Total Return | 18.37% | |||
| 5-Year Total Return | -3.93% | |||
| 52-Week High % Change | -10.96% | |||
| 52-Week Low % Change | 97.25% | |||
| Price | PAHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $26.55 | |||
| 52-Week Low Price | $11.99 | |||
| 52-Week Low Price (Date) | Mar 14, 2024 | |||
| 52-Week High Price (Date) | Feb 18, 2025 | |||
| Valuation | PAHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 957.51M | |||
| Enterprise Value | 1.67B | |||
| Price/Earnings (TTM) | 49.80 | |||
| Earnings Per Share (TTM) | 0.47 | |||
| Earnings Per Share Growth | 31.21% | |||
| Price/Earnings To Growth | 1.60 | |||
| Price/Sales (TTM) | 0.87 | |||
| Price/Book (Q) | 3.88 | |||
| Enterprise Value/Revenue (TTM) | 1.51 | |||
| Price | $23.64 | |||
| Enterprise Value/EBITDA (TTM) | 12.07 | |||
| Enterprise Value/EBIT | 16.55 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | PAHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 40.72M | |||
| Dividend Yield | 2.03% | |||
| Div. Per Share (Most Recent) | $0.12 | |||
| Dividend Per Share (TTM) | $0.48 | |||
| Payout Ratio (TTM) | 100.64% | |||
| Dividend Per Share (Most Recent) | $0.12 | |||
| Company Info | PAHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 201 329 7300 | |||
| Address | Glenpointe Centre East Teaneck, NJ 07666-6712 | |||
| Website | www.pahc.com | |||
| Country | United States | |||
| Year Founded | 1946 | |||
| Profitability | PAHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 9.14% | |||
| Profit Margin | 1.74% | |||
| Management Effectiveness | PAHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 5.60% | |||
| Return on Equity | 7.46% | |||
| Income Statement | PAHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 1.11B | |||
| Total Revenue (TTM) | 1.11B | |||
| Revenue Per Share | $27.17 | |||
| Gross Profit (TTM) | 353.96M | |||
| EBITDA (TTM) | 138.70M | |||
| EBIT (TTM) | 101.16M | |||
| Net Income (TTM) | 19.32M | |||
| Net Income Avl. to Common (TTM) | 19.32M | |||
| Total Revenue Growth (Q YOY) | 23.73% | |||
| Earnings Growth (Q YOY) | 150.00% | |||
| EPS Diluted (TTM) | 0.47 | |||
| EPS Diluted Growth (Q YOY) | 162.00% | |||
| Balance Sheet | PAHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 73.98M | |||
| Cash Per Share (Q) | $1.82 | |||
| Total Current Assets (Q) | 746.15M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 246.80M | |||
| Current Ratio (Q) | 3.199 | |||
| Book Value Per Share (Q) | $6.09 | |||
| Total Assets (Q) | 1.29B | |||
| Total Current Liabilities (Q) | 233.25M | |||
| Total Debt (Q) | 790.76M | |||
| Total Liabilities (Q) | 1.04B | |||
| Total Common Equity (Q) | 246.80M | |||
| Cash Flow | PAHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -271.38M | |||
| Cash from Financing (TTM) | 253.76M | |||
| Net Change in Cash (TTM) | 34.10M | |||
| Levered Free Cash Flow (TTM) | -91.08M | |||
| Cash from Operations (TTM) | 55.54M | |||
